Brian K. Kennedy, Dudley W. Lamming  Cell Metabolism 

Slides:



Advertisements
Similar presentations
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease  Konrad Talbot, Hoau-Yan Wang 
Advertisements

Volume 13, Issue 2, Pages (February 2011)
AMPK—Sensing Energy while Talking to Other Signaling Pathways
IRS-1: Auditing the effectiveness of mTOR inhibitors
All roads lead to FoxO Cell Metabolism
A CRTCal Link between Energy and Life Span
AMPK-Dependent Phosphorylation of ULK1 Induces Autophagy
Figure 1 mTOR pathway activation
Nutrient-Sensing Mechanisms across Evolution
The Akt-mTOR tango and its relevance to cancer
Volume 23, Issue 3, Pages (March 2016)
Kinase inhibitors: Vice becomes virtue
Taking T Cell Priming Down a Notch: Signaling through Notch Receptors Enhances T Cell Sensitivity to Antigen  Timothy J. Thauland, Manish J. Butte  Immunity 
A Flt3L Encounter: mTOR Signaling in Dendritic Cells
mTORC1: Turning Off Is Just as Important as Turning On
Figure 3 Physiological regulation of autophagy in the heart
Figure 1 mTOR complex biology
In-vitro regulation of primordial follicle activation: challenges for fertility preservation strategies  Michael J. Bertoldo, Kirsty A. Walters, William.
The pathway signalling starts with the binding of insulin or growth factors to insulin receptors. The pathway signalling starts with the binding of insulin.
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Maria M. Mihaylova, David M. Sabatini, Ömer H. Yilmaz  Cell Stem Cell 
Primary Cilia Bend LKB1 and mTOR to Their Will
Identification of TOR Signaling Complexes
Is REDD1 a Metabolic Éminence Grise?
A New Link in the Chain from Amino Acids to mTORC1 Activation
Independent Control of Aging and Axon Regeneration
Complementing T Cells’ Functions: Bringing in Metabolism Matters
Volume 13, Issue 2, Pages (February 2011)
Rapamycin: One Drug, Many Effects
Autophagy: A Sweet Process in Diabetes
FGFR Signaling as a Target for Lung Cancer Therapy
Autophagy: A Potential Link between Obesity and Insulin Resistance
Autophagy in kidney disease and aging: lessons from rodent models
IRS-1: Auditing the effectiveness of mTOR inhibitors
An Emerging Role of mTOR in Lipid Biosynthesis
AMPK—Sensing Energy while Talking to Other Signaling Pathways
mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells
The Pioneer Round of Translation: Features and Functions
Russell G. Jones, Edward J. Pearce  Immunity 
Volume 18, Issue 1, Pages (July 2013)
Live Longer sans the AT1A Receptor
Estrogen Receptors and the Metabolic Network
AKT/PKB Signaling: Navigating the Network
PRAS40 Is an Insulin-Regulated Inhibitor of the mTORC1 Protein Kinase
Figure 1 The mTOR signalling pathway
The Dawn of the Age of Amino Acid Sensors for the mTORC1 Pathway
Insulin Action under Arrestin
Proteins Kinases: Chromatin-Associated Enzymes?
AKT/PKB Signaling: Navigating Downstream
Volume 32, Issue 1, Pages (October 2008)
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism  Barbara B. Kahn, Thierry Alquier, David Carling,
Rapamycin: One Drug, Many Effects
Insulin Resistance in the Defense against Obesity
Volume 58, Issue 5, Pages (June 2015)
mTOR and Akt Signaling in Cancer: SGK Cycles In
Alex Kentsis, A. Thomas Look  Cell Stem Cell 
Volume 32, Issue 1, Pages (October 2008)
Shared Principles in NF-κB Signaling
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease  Konrad Talbot, Hoau-Yan Wang 
Tobias B. Huber, Gerd Walz, E Wolfgang Kuehn  Kidney International 
Role reversal: Brain insulin and liver STAT3
Autophagy in the Cellular Energetic Balance
Dysregulation of the mTOR Pathway Secondary to Mutations or a Hostile Microenvironment Contributes to Cancer and Poor Wound Healing  Richard A.F. Clark,
Lysosomal Rag-ulation of mTOR Complex 1 Activity
Volume 24, Issue 1, Pages 7-8 (July 2016)
Volume 57, Issue 2, Pages (January 2015)
Toward a Molecular Definition of Leucine-Dependent mTORC1 Activation
Turning Reciprocal Feedback Regulation into Combination Therapy
T Helper Cell Differentiation: Understanding the Needs of Hierarchy
The Ribosome and TORC2: Collaborators for Cell Growth
Presentation transcript:

The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging  Brian K. Kennedy, Dudley W. Lamming  Cell Metabolism  Volume 23, Issue 6, Pages 990-1003 (June 2016) DOI: 10.1016/j.cmet.2016.05.009 Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 1 mTORC1, a Central Regulator of Metabolism Regulation of metabolic processes downstream of mTORC1, with major known substrates and metabolic processes highlighted. Protein kinases, including mTORC1, are boxed in red. The core proteins of mTORC1—mTOR, Raptor, and mLST8—are depicted as interacting directly with the mTOR kinase, whereas proteins with nutrient-sensitive or transient interactions with the mTORC1 core—DEPTOR, PRAS40, and Tel2/Tti1—are depicted in a separate, adjacent box. Proteins that regulate the localization of mTORC1 to the lysosome, e.g., the Rag GTPases and the Ragulator and GATOR complexes, are not depicted. Cell Metabolism 2016 23, 990-1003DOI: (10.1016/j.cmet.2016.05.009) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 2 mTORC2, a Major Effector of the Insulin/IGF-1 Signaling Pathway Regulation of metabolic processes downstream of mTORC2, with major known substrates and metabolic processes highlighted. Protein kinases, including mTORC2, are boxed in red. The core proteins of mTORC2—mTOR, Rictor, mLST8, mSin1, and Protor—are depicted as interacting directly with the mTOR kinase, whereas proteins with nutrient-sensitive or transient interactions with the mTORC2 core—DEPTOR, IKK, Sestrin3, Tel2/Tti1, and Xpln—are depicted in a separate, adjacent box. The TSC complex—in particular, TSC2—interacts with and regulates mTORC2 (Huang et al., 2008), but it is not clear if or how this interaction is regulated. Dashed box: insulin stimulates mTORC1 through the AKT-mediated phosphorylation of specific sites on TSC2 and PRAS40 (Menon et al., 2014; Sancak et al., 2007), but the requirement for mTORC2 in the insulin-mediated activation of mTORC1 remains unclear. Extracellular signals in addition to insulin, IGF-1, and leptin that regulate PI3K or PIP3 may also regulate mTORC2 activity, but these are not depicted here. Cell Metabolism 2016 23, 990-1003DOI: (10.1016/j.cmet.2016.05.009) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 3 Regulation of mTORC1 Activity by Amino Acids and Insulin (A) In the absence of amino acids and insulin, mTORC1 is found in the cytoplasm, while TSC localizes to the lysosome. (B) Amino acids result in the inhibition of GATOR1 by GATOR2, the activation of the Rag GTPases, the localization of mTORC1 to the lysosome, and the recruitment of Rheb to the lysosome by MCRS1. TSC continues to inhibit Rheb, and thus mTORC1 remains inactive. (C) Insulin induces TSC to leave the lysosome, permitting Rheb to bind to GTP; insulin also stimulates the disassociation of PRAS40 from mTORC1. mTORC1 can then interact with GTP-bound Rheb and become active. Cell Metabolism 2016 23, 990-1003DOI: (10.1016/j.cmet.2016.05.009) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 4 The Action of Rapamycin against mTORC1 or mTORC2 Is Dependent upon FK506-Binding Proteins Rapamycin binding to either FKBP12 or FKBP51 forms a complex that can then act to inhibit mTORC1. However, inhibition of mTORC2 activity by rapamycin is dependent upon a rapamycin-FKBP12 complex that can prevent the formation of mTORC2 by binding to free mTOR, preventing the incorporation of mTOR into mTORC2. The relative expression level of FKBP12 and FKBP51 determines the rapamycin sensitivity of mTORC2 in each cell line or tissue. Cell Metabolism 2016 23, 990-1003DOI: (10.1016/j.cmet.2016.05.009) Copyright © 2016 Elsevier Inc. Terms and Conditions